RxDoctor Payments Data

Ammara Mushtaq, MD

Infectious Disease · Gainesville, FLNPI 1013361450

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $876 of the $1,348 with a category attached, or 65.0%. Modernatx, Inc. accounts for 94.5% of it on its own, with 2 other manufacturers making up the rest.

$1,348in general payments, 2019–2025

Across 12 payments — averaging $112.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$1K
  • Merck$39
  • Shionogi Inc$35
$2,694,634in research payments, 2019–2025

Across 90 payments — averaging $29,940 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$1.7M
  • Vertex$604K
  • Cleerly, Inc.$311K
  • Merck$88K
  • Amgen$8K

What the payments were for

  • Travel & lodging$87665%
  • Food & beverage$43732%
  • Education$353%

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.10$1,274
Merck1$39
Shionogi Inc1$35

How this compares

$1,348 in reported general payments places this provider in the 60th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida

Medicare billing

Part B allowed, 2024
$1,969
Medicare patients
12
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate13$240

Paid to pharmacies, not to this prescriber.

Other infectious disease in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →